We are live on ! Find out more
ILI

INTERLEUKIN GENETICS INC
ILI

Delisted

ILI was delisted on the 13th of August, 2010.

Back to rankings

1 hedge funds and large institutions have $46K invested in INTERLEUKIN GENETICS INC in 2015 Q2 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

10% more capital invested

Capital invested by funds: $42K → $46K (+$4K)

0% more funds holding

Funds holding: 1 → 1 (0)

Holders
1
Holders Change
–
Holders Change %
0%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
CL
CPWM LLC
Washington
+$6.99K

Top Sellers

No sellers this quarter

ILI Hedge Fund Activity: Q2 2015 in Review

1 of the 3,730 institutional investors tracked by Wall St. Rank reported a position in INTERLEUKIN GENETICS INC (ILI) for Q2 2015, worth a combined $46K — up 9.5% from $42K a quarter earlier.

Fund positioning in ILI was balanced in Q2 2015: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 0 trimmed.

The largest buyer was CPWM LLC, adding an estimated $6.99K.

  • 1 institutional investor held INTERLEUKIN GENETICS INC (ILI) as of Q2 2015, unchanged from Q1 2015.
  • Funds reported $46K of INTERLEUKIN GENETICS INC stock for Q2 2015, up 9.5% quarter-over-quarter.
  • 0 funds opened new INTERLEUKIN GENETICS INC positions in Q2 2015 and 0 closed out.
  • The largest INTERLEUKIN GENETICS INC buyer in Q2 2015 was CPWM LLC, an estimated $6.99K added.

Based on aggregated 13F filings for Q2 2015.